Market research
HSDT Helius Medical Technologies Inc Class A
NASDAQ USD Financial Services
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 147M
- P/E ratio
- 0.04
- Analyst target
- 3.5
- Dividend yield
- Not available
- Beta
- 1.12
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Financial Services
- Industry
- Asset Management
- ISIN
- Not available
- Market cap
- 147M
- P/E ratio
- 0.04
- Analyst target
- 3.5
- Dividend yield
- Not available
- Beta
- 1.12
About
About Helius Medical Technologies Inc Class A
Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications. It also focuses on neurological wellness. In addition, the company offers Portable Neuromodulation Stimulator, a non-implantable medical device, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. Solana Company is headquartered in Newtown, Pennsylvania.
Research context
Helius Medical Technologies Inc Class A appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Financial Services
- Industry
- Asset Management
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the HSDT discussion.
5 years, 7 months ago
Helius Medical Technologies, Inc is currently in a long term uptrend where the price is trading 12.5% above its 200 day moving average.
From a valuation standpoint, the stock is 97.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 32.5.
Helius Medical Technologies, Inc's total revenue rose by 25.7% to $191K since the same quarter in the previous year.
Its net income has increased by 52.4% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 52.1% to $-2M since the same quarter in the previous year.
Based on the above factors, Helius Medical Technologies, Inc gets an overall score of 5/5.